{"altmetric_id":16042588,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":25},"twitter":{"unique_users_count":20,"unique_users":["TrueDiagnostics","UrologyMatch","JUrology","echartierkastle","actasurologicas","sbinhamri","sbinhamrii","doctorshep","ClaireJTaylor1","ResidentesAEU","moisessocarras","BMUrology","UroOnco","ESRUrology","DrSohailUro","UROLOGYFUTURE","maperrouinverbe","peepeeDoctor","HAUROFPMRS","Arun_Sujen"],"posts_count":24},"facebook":{"unique_users_count":1,"unique_users":["158509396977"],"posts_count":1}},"selected_quotes":["RCT: 100 units Botox sig greater \u2193 incontinence than solifenacin with 1\/3 pts achieving 100% incontinence \u2193","When there is no data that Vesicare is better than other anticholinergic medications then would it work in refractory OAB?","The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Refractory OAB","Are you wondering if payors will fulfill their duty to cover proven therapies instead of continued obstructionism? Me neither - they won't","The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin-Na\u00efve Patients w\u2026"],"citation":{"abstract":"This double-blind, randomized study compared the efficacy\/safety of onabotulinumtoxinA or solifenacin versus placebo in overactive bladder patients with urinary incontinence who had an inadequate response to\/were intolerant of an anticholinergic. A post-hoc analysis compared effects of onabotulinumtoxinA versus solifenacin.\nSolifenacin-na\u00efve patients were randomized to onabotulinumtoxinA 100U, solifenacin 5mg (could escalate to 10mg at week 6 with predefined criteria), or placebo. Patients could request treatment 2 (open-label onabotulinumtoxinA) after fulfilling prespecified criteria. Endpoints included change from baseline in urinary incontinence episodes\/day and proportions of patients with 100% reduction (\"dry\") in incontinence episodes\/day (co-primaries), other urinary symptoms, and quality of life, all at week 12, and adverse events.\nChange from baseline in incontinence episodes\/day was significantly greater with onabotulinumtoxinA (-3.19) or solifenacin (-2.56) vs placebo (-1.33; both p<0.001 vs placebo); incontinence reduction was significantly greater for onabotulinumtoxinA vs solifenacin (p=0.022). At week 12, 33.8% (p<0.001 vs placebo), 24.5% (p=0.028 vs placebo), and 11.7% of onabotulinumtoxinA, solifenacin, and placebo patients were \"dry,\" respectively; after treatment 2 (open-label onabotulinumtoxinA), 43.2%, 37.6%, and 41.9% of patients in each respective group were \"dry.\" Significant improvements in other urinary symptoms and quality of life were observed in both active treatments. Urinary tract infection (25.5%) and retention (6.9%) were more common with onabotulinumtoxinA.\nThe efficacies of both onabotulinumtoxinA and solifenacin were significantly higher than placebo, but onabotulinumtoxinA showed significantly greater reductions in urinary incontinence than solifenacin, with one-third achieving 100% incontinence reduction. No unexpected safety signals were observed.","altmetric_jid":"4f6fa62b3cf058f610007f12","authors":["Sender Herschorn","Alfred Kohan","Philip Aliotta","Kurt McCammon","Rajagopalan Sriram","Steven Abrams","Wayne Lam","Karel Everaert"],"doi":"10.1016\/j.juro.2017.01.069","first_seen_on":"2017-02-02T00:59:38+00:00","funders":["niehs"],"handle":"1854\/LU-8510137","handles":["1854\/LU-8510137"],"issns":["00225347","1527-3792"],"journal":"The Journal of Urology","last_mentioned_on":1500012465,"links":["http:\/\/www.jurology.com\/article\/S0022-5347(17)30189-1\/fulltext?rss=yes","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=3&redirect=http%3A%2F%2Fwww.jurology.com%2Farticle%2FS0022-5347%2817%2930189-1%2Ffulltext%3Frss%3Dyes&code=juro-site","https:\/\/doi.org\/10.1016\/j.juro.2017.01.069","http:\/\/www.jurology.com\/article\/S0022-5347(17)30189-1\/fulltext"],"pdf_url":"http:\/\/www.jurology.com\/article\/S0022534717301891\/pdf","pmid":"28161352","pubdate":"2017-02-01T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin-Na\u00efve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind, Phase 3b Trial","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022534717301891","mendeley_url":"http:\/\/www.mendeley.com\/research\/efficacy-safety-onabotulinumtoxina-solifenacin-compared-placebo-solifenacin-na%C3%AFve-patients-refractor"},"altmetric_score":{"score":12.1,"score_history":{"1y":12.1,"6m":10.6,"3m":10.6,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.1},"context_for_score":{"all":{"total_number_of_other_articles":8208063,"mean":6.9506291146371,"rank":687809,"this_scored_higher_than_pct":91,"this_scored_higher_than":7518595,"rank_type":"exact","sample_size":8208063,"percentile":91},"similar_age_3m":{"total_number_of_other_articles":265818,"mean":12.827643837677,"rank":36250,"this_scored_higher_than_pct":86,"this_scored_higher_than":229462,"rank_type":"exact","sample_size":265818,"percentile":86},"this_journal":{"total_number_of_other_articles":8239,"mean":4.8273505705268,"rank":512,"this_scored_higher_than_pct":93,"this_scored_higher_than":7723,"rank_type":"exact","sample_size":8239,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":385,"mean":5.87109375,"rank":48,"this_scored_higher_than_pct":87,"this_scored_higher_than":337,"rank_type":"exact","sample_size":385,"percentile":87}}},"demographics":{"poster_types":{"member_of_the_public":12,"researcher":3,"practitioner":2,"science_communicator":3},"users":{"twitter":{"cohorts":{"Members of the public":12,"Science communicators (journalists, bloggers, editors)":3,"Scientists":3,"Practitioners (doctors, other healthcare professionals)":2}},"mendeley":{"by_status":[],"by_discipline":[]}},"geo":{"twitter":{"US":6,"FR":2,"ES":3,"DJ":1,"GB":2,"BR":1,"PK":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/TrueDiagnostics\/statuses\/826958161429032962","license":"gnip","citation_ids":[16042588],"posted_on":"2017-02-02T00:59:24+00:00","author":{"name":"Jerry Lee","url":"http:\/\/www.truediag.com","image":"https:\/\/pbs.twimg.com\/profile_images\/567483990097936384\/6uKJglvi_normal.jpeg","description":"We specialize in providing quick & simple quantitative test systems designed for point-of-care monitoring. Test results in minutes not days..","id_on_source":"TrueDiagnostics","tweeter_id":"317232537","geo":{"lt":32.71533,"ln":-117.15726,"country":"US"},"followers":379},"tweet_id":"826958161429032962"},{"url":"http:\/\/twitter.com\/UrologyMatch\/statuses\/826962599828922368","license":"gnip","citation_ids":[16042588],"posted_on":"2017-02-02T01:17:02+00:00","author":{"name":"Urology Match","url":"http:\/\/www.urologymatch.com","image":"https:\/\/pbs.twimg.com\/profile_images\/670243589750935552\/vkJCRb_7_normal.jpg","description":"Premier Internet portal to keep abreast of the exciting field of Urology. Founded in 2003 by @uretericbud and @wandering_gu. SoMe Editor @McAGES.","id_on_source":"UrologyMatch","tweeter_id":"57250389","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":8014},"tweet_id":"826962599828922368"},{"url":"http:\/\/twitter.com\/JUrology\/statuses\/878251575281688577","license":"gnip","citation_ids":[16042588],"posted_on":"2017-06-23T14:01:07+00:00","author":{"name":"Journal of Urology","url":"http:\/\/www.jurology.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/463353475724619776\/AF3_S0px_normal.jpeg","description":"The official Twitter page of The Journal of Urology\u00ae","id_on_source":"JUrology","tweeter_id":"309162907","geo":{"lt":39.20511,"ln":-76.65275,"country":"US"},"followers":15118},"tweet_id":"878251575281688577"},{"url":"http:\/\/twitter.com\/echartierkastle\/statuses\/878254368025227264","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-23T14:12:13+00:00","author":{"name":"chartier-kastler e \u0646","url":"http:\/\/www.upmc.fr","image":"https:\/\/pbs.twimg.com\/profile_images\/658173255254220800\/RIjHyaH5_normal.jpg","id_on_source":"echartierkastle","tweeter_id":"1033036932","geo":{"lt":46,"ln":2,"country":"FR"},"followers":318},"tweet_id":"878254368025227264"},{"url":"http:\/\/twitter.com\/actasurologicas\/statuses\/878262396149694466","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-23T14:44:07+00:00","author":{"name":"actasurologicas","url":"http:\/\/www.elsevier.es\/actasuro","image":"https:\/\/pbs.twimg.com\/profile_images\/593042573003988993\/BlfpwpUq_normal.png","description":"La revista Actas Urol\u00f3gicas Espa\u00f1olas es el \u00f3rgano de expresi\u00f3n cient\u00edfica de las Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda(AEU) y de la Conf. Americana de Urolog\u00eda(CAU)","id_on_source":"actasurologicas","tweeter_id":"3217062466","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":1248},"tweet_id":"878262396149694466"},{"url":"http:\/\/twitter.com\/sbinhamri\/statuses\/878264978691600384","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-23T14:54:22+00:00","author":{"name":"\u062f. \u0633\u0639\u064a\u062f \u0628\u0646 \u062d\u0645\u0631\u064a","url":"http:\/\/www.petraurogroup.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/877741573093687300\/vngmWj1M_normal.jpg","description":"#\u0627\u0633\u062a\u0634\u0627\u0631\u064a \u062c\u0631\u0627\u062d\u0629 #\u0627\u0644\u0645\u0633\u0627\u0644\u0643 #\u0627\u0644\u0628\u0648\u0644\u064a\u0629 \u0623\u0633\u062a\u0627\u0630 \u0645\u0633\u0627\u0639\u062f \u0633\u0627\u0628\u0642 \u062c\u0627\u0645\u0639\u0629 #\u0628\u0627\u0631\u064a\u0633 \u0666\u060c\u0645\u064f\u062d\u0627\u0636\u0631 #\u062f\u0648\u0644\u064a \u0628 #\u0627\u0644\u0641\u0631\u0646\u0633\u064a\u0629 \u0648 #\u0627\u0644\u0625\u0646\u062c\u0644\u064a\u0632\u064a\u0629 \u0644 #\u0645\u0646\u0627\u0638\u064a\u0631 #\u0644\u064a\u0632\u0631 #\u062d\u0635\u0649 #\u0627\u0644\u0643\u0644\u0649 \u0628\u0627\u0644\u0634\u0631\u0642 \u0627\u0644\u0623\u0648\u0633\u0637 \u0648 \u0634\u0645\u0627\u0644 \u0627\u0641\u0631\u064a\u0642\u064a\u0627","id_on_source":"sbinhamri","tweeter_id":"746311443436474369","geo":{"lt":null,"ln":null},"followers":755},"tweet_id":"878264978691600384"},{"url":"http:\/\/twitter.com\/sbinhamrii\/statuses\/878264686738722818","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-23T14:53:13+00:00","author":{"name":"Saeed Bin Hamri \u2122\u27b0","url":"http:\/\/linkedin.com\/in\/saeed-bin-hamri-md-9327a476","image":"https:\/\/pbs.twimg.com\/profile_images\/850794483759427584\/5YZQ3BAV_normal.jpg","description":"Consultant Urology, Advanced #Endourology - Passionate #Urinary #Stone, #Laser , #MIS & #Urotechnology (French\/English) #NGHA #Riyadh, Saudi Arabia","id_on_source":"sbinhamrii","tweeter_id":"636426266","geo":{"lt":11.5,"ln":42.5,"country":"DJ"},"followers":910},"tweet_id":"878264686738722818"},{"url":"http:\/\/twitter.com\/doctorshep\/statuses\/878345473550991360","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-23T20:14:14+00:00","author":{"name":"Chris Schrepferman","url":"http:\/\/www.drshep.com","image":"https:\/\/pbs.twimg.com\/profile_images\/635587452820918272\/PhDUsbtO_normal.jpg","description":"Father to 3 great boys, vasectomy reversal specialist, male infertility, horse racing fan, love Louisville, married to great woman and mother Rachel","id_on_source":"doctorshep","tweeter_id":"280567591","geo":{"lt":38.25424,"ln":-85.75941,"country":"US"},"followers":285},"tweet_id":"878345473550991360"},{"url":"http:\/\/twitter.com\/ClaireJTaylor1\/statuses\/878381207565807618","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-23T22:36:14+00:00","author":{"name":"Claire Taylor","image":"https:\/\/pbs.twimg.com\/profile_images\/587040187777167360\/Tr2-Y-uT_normal.jpg","description":"Consultant Urologist Guys and Kings College Hospitals, London. Specialist interest Functional Reconstructive and Adolescent Urology.  All views are my own.","id_on_source":"ClaireJTaylor1","tweeter_id":"3107473619","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":164},"tweet_id":"878381207565807618"},{"url":"http:\/\/twitter.com\/ResidentesAEU\/statuses\/878947379331948545","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-25T12:05:59+00:00","author":{"name":"Residentes Urolog\u00eda","url":"http:\/\/residentes.aeu.es","image":"https:\/\/pbs.twimg.com\/profile_images\/789810867470827520\/PNe-xaPQ_normal.jpg","description":"Grupo de Trabajo de Residentes y J\u00f3venes Ur\u00f3logos de la Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda (@infoAEU)","id_on_source":"ResidentesAEU","tweeter_id":"3247636187","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":2070},"tweet_id":"878947379331948545"},{"url":"http:\/\/twitter.com\/moisessocarras\/statuses\/878954540338483200","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-25T12:34:27+00:00","author":{"name":"Moises Socarras","image":"https:\/\/pbs.twimg.com\/profile_images\/856048174066274304\/9fjjqhd__normal.jpg","description":"Urologist,FEBU webmaster of @ESRUrology Team @residentesAEU Interest: Social Media, New technology, Laparoscopy, Prostate, bladder, kidney Ca. Views are my own.","id_on_source":"moisessocarras","tweeter_id":"155001980","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1506},"tweet_id":"878954540338483200"},{"url":"http:\/\/twitter.com\/BMUrology\/statuses\/878999524739612673","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-25T15:33:12+00:00","author":{"name":"Bryn Mawr Urology","url":"http:\/\/www.brynmawrurology.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/230582896\/DVDlabel_sm_normal.GIF","description":"610-525-6580 Provides patients with state of the art urological care including minimally invasive robotic and laparoscopic surgery.","id_on_source":"BMUrology","tweeter_id":"42522771","geo":{"lt":null,"ln":null},"followers":572},"tweet_id":"878999524739612673"},{"url":"http:\/\/twitter.com\/UroOnco\/statuses\/879212287034355712","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-26T05:38:38+00:00","author":{"name":"Fl\u00e1vio Lobo Heldwein","url":"http:\/\/www.uroonco.org","image":"https:\/\/pbs.twimg.com\/profile_images\/894255740227112960\/p1itQBTX_normal.jpg","description":"Professor #Urologia @Unisul_Univ @UFSC PhD fellowship laparoscopia e rob\u00f3tica #qualidadedeVida Blog #Sa\u00fadedoHomem @clicrbsRS Ciclismo. views=mine. RTs\u2260E","id_on_source":"UroOnco","tweeter_id":"57997565","geo":{"lt":-27.59667,"ln":-48.54917,"country":"BR"},"followers":305},"tweet_id":"879212287034355712"},{"url":"http:\/\/twitter.com\/ESRUrology\/statuses\/880012200743755778","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-28T10:37:13+00:00","author":{"name":"ESRUrology","url":"http:\/\/esru.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/628904415936802816\/KiWUovKO_normal.jpg","description":"The European Society of Residents in Urology (ESRU) was founded in 1991 as the body representing the trainees in urology in Europe.","id_on_source":"ESRUrology","tweeter_id":"3131789745","geo":{"lt":null,"ln":null},"followers":3581},"tweet_id":"880012200743755778"},{"url":"http:\/\/twitter.com\/DrSohailUro\/statuses\/880103726094196737","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-06-28T16:40:54+00:00","author":{"name":"Dr. Sohail","image":"https:\/\/pbs.twimg.com\/profile_images\/889349282880532480\/uDr9bFtH_normal.jpg","description":"#Consultant Urologist #doctor #kidneys #stones #prostate #cancer #bladder #laproscopy #pcnl #lasersurgery #Gemini #art Lahore. RTs \u2260 endorsements","id_on_source":"DrSohailUro","tweeter_id":"2563121641","geo":{"lt":31.54972,"ln":74.34361,"country":"PK"},"followers":505},"tweet_id":"880103726094196737"},{"url":"http:\/\/twitter.com\/JUrology\/statuses\/880803591581294592","license":"gnip","citation_ids":[16042588],"posted_on":"2017-06-30T15:01:55+00:00","author":{"name":"Journal of Urology","url":"http:\/\/www.jurology.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/463353475724619776\/AF3_S0px_normal.jpeg","description":"The official Twitter page of The Journal of Urology\u00ae","id_on_source":"JUrology","tweeter_id":"309162907","geo":{"lt":39.20511,"ln":-76.65275,"country":"US"},"followers":15118},"tweet_id":"880803591581294592"},{"url":"http:\/\/twitter.com\/doctorshep\/statuses\/880807254898954240","license":"gnip","citation_ids":[16042588],"posted_on":"2017-06-30T15:16:28+00:00","author":{"name":"Chris Schrepferman","url":"http:\/\/www.drshep.com","image":"https:\/\/pbs.twimg.com\/profile_images\/635587452820918272\/PhDUsbtO_normal.jpg","description":"Father to 3 great boys, vasectomy reversal specialist, male infertility, horse racing fan, love Louisville, married to great woman and mother Rachel","id_on_source":"doctorshep","tweeter_id":"280567591","geo":{"lt":38.25424,"ln":-85.75941,"country":"US"},"followers":285},"tweet_id":"880807254898954240"},{"url":"http:\/\/twitter.com\/UROLOGYFUTURE\/statuses\/881157715694936064","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-07-01T14:29:05+00:00","author":{"name":"Urology Future","url":"http:\/\/linkedin.com\/in\/daniel-melecchi-freitas-md-30480a126","image":"https:\/\/pbs.twimg.com\/profile_images\/718967863113965568\/IyDnE3Ei_normal.jpg","description":"#Urology #Robotics #VirtualReality#Nanotech #Biomarkers#Oncology.Daniel Melecchi Freitas MD-Chief of Urology Res Program at GHC","id_on_source":"UROLOGYFUTURE","tweeter_id":"718802868518563840","geo":{"lt":null,"ln":null},"followers":1678},"tweet_id":"881157715694936064"},{"url":"http:\/\/twitter.com\/moisessocarras\/statuses\/881200427852861440","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-07-01T17:18:48+00:00","author":{"name":"Moises Socarras","image":"https:\/\/pbs.twimg.com\/profile_images\/856048174066274304\/9fjjqhd__normal.jpg","description":"Urologist,FEBU webmaster of @ESRUrology Team @residentesAEU Interest: Social Media, New technology, Laparoscopy, Prostate, bladder, kidney Ca. Views are my own.","id_on_source":"moisessocarras","tweeter_id":"155001980","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1506},"tweet_id":"881200427852861440"},{"url":"http:\/\/twitter.com\/maperrouinverbe\/statuses\/881991659407409155","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-07-03T21:42:52+00:00","author":{"name":"MAPERROUIN-VERBE","image":"https:\/\/pbs.twimg.com\/profile_images\/814125409700892672\/8n1Q91pd_normal.jpg","id_on_source":"maperrouinverbe","tweeter_id":"800080225652486144","geo":{"lt":47.21725,"ln":-1.55336,"country":"FR"},"followers":54},"tweet_id":"881991659407409155"},{"url":"http:\/\/twitter.com\/peepeeDoctor\/statuses\/885674863096188929","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-07-14T01:38:37+00:00","author":{"name":"Khurshid Ghani","url":"http:\/\/medicine.umich.edu\/dept\/urology\/khurshid-ridwan-ghani-mb-bch","image":"https:\/\/pbs.twimg.com\/profile_images\/465243112462229504\/qDBPVsi-_normal.jpeg","description":"Associate Professor, @UMichUrology | Co-Director @MUSICurology | Assistant Editor @JUrology | Course Director http:\/\/dustcme.com *Views expressed are my own*","id_on_source":"peepeeDoctor","tweeter_id":"154302704","geo":{"lt":42.27756,"ln":-83.74088,"country":"US"},"followers":2244},"tweet_id":"885674863096188929"},{"url":"http:\/\/twitter.com\/HAUROFPMRS\/statuses\/885705424816754688","license":"gnip","citation_ids":[16042588],"posted_on":"2017-07-14T03:40:03+00:00","author":{"name":"Himanshu Aggarwal","image":"https:\/\/pbs.twimg.com\/profile_images\/728687412872773636\/5kmhauMV_normal.jpg","description":"Clinical Assistant Professor #UABUrology #Urologist|#FPMRS|#Urogynecologist| #nativetissue repair for #incontinence|#Prolapse| & explant of #Pelvicmesh","id_on_source":"HAUROFPMRS","tweeter_id":"103708208","geo":{"lt":32.36681,"ln":-86.29997,"country":"US"},"followers":171},"tweet_id":"885705424816754688"},{"url":"http:\/\/twitter.com\/HAUROFPMRS\/statuses\/885706577155686401","license":"gnip","citation_ids":[16042588],"posted_on":"2017-07-14T03:44:38+00:00","author":{"name":"Himanshu Aggarwal","image":"https:\/\/pbs.twimg.com\/profile_images\/728687412872773636\/5kmhauMV_normal.jpg","description":"Clinical Assistant Professor #UABUrology #Urologist|#FPMRS|#Urogynecologist| #nativetissue repair for #incontinence|#Prolapse| & explant of #Pelvicmesh","id_on_source":"HAUROFPMRS","tweeter_id":"103708208","geo":{"lt":32.36681,"ln":-86.29997,"country":"US"},"followers":171},"tweet_id":"885706577155686401"},{"url":"http:\/\/twitter.com\/Arun_Sujen\/statuses\/885742595217010689","license":"gnip","rt":["JUrology"],"citation_ids":[16042588],"posted_on":"2017-07-14T06:07:45+00:00","author":{"name":"Arun Sujenthiran","image":"https:\/\/pbs.twimg.com\/profile_images\/425759113864163328\/KHuMej6m_normal.jpeg","description":"Trainee Urological Surgeon, London. National Prostate Cancer Audit Fellow, RCS(Eng). Views my own.","id_on_source":"Arun_Sujen","tweeter_id":"1411517330","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":99},"tweet_id":"885742595217010689"}],"facebook":[{"title":"The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155749341396978&id=158509396977","license":"public","citation_ids":[16042588],"posted_on":"2017-02-02T01:31:17+00:00","summary":"This double-blind, randomized study compared the efficacy\/safety of onabotulinumtoxinA or solifenacin versus placebo in overactive bladder patients...","author":{"name":"UrologyMatch","url":"https:\/\/www.facebook.com\/158509396977","facebook_wall_name":"UrologyMatch","image":"https:\/\/graph.facebook.com\/158509396977\/picture","id_on_source":"158509396977"}}]}}